Literature DB >> 12114768

Papillary Thyroid Carcinoma Overexpresses Fully and Underglycosylated Mucins Together with Native and Sialylated Simple Mucin Antigens and Histo-Blood Group Antigens.

Pedro Alves1, Paula Soares, Elsa Fonseca, Manuel Sobrinho-Simões.   

Abstract

We studied the immunohistochemical expression of mucins (MUC1, underglycosylated MUC1, MUC2, MUC5AC, and MUC6), simple mucin antigens (Tn, sialyl Tn, and T), and histo-blood group antigens (type 1-Lewis(a) and sialyl Lewis(a) type 2-Lewis(x) and sialyl Lewis(x)) in a series of 26 papillary thyroid carcinomas (PTC), 6 follicular carcinomas, and a control group of 32 cases of "normal" thyroid parenchyma adjacent to the tumors. PTC expressed more often, more intensively, and more extensively every antigen but MUC6, which was not observed in any case. The expression of MUC5AC was also extremely rare. MUC1 expression was related to the expression of underglycosylated MUC1, MUC2, Lewis(a), and sialyl Lewis(a). A trend toward an association between the expression of MUC1 and that of type 2 histo-blood group antigens was also observed. Whenever there was a dissociation between the expression of type 1 and type 2 Lewis antigens, MUC1 appeared closely related to type 1 and independent from type 2 histo-blood group antigens. We conclude that MUC1 plays a pivotal, though not exclusive, role in the glycosylation features of well differentiated thyroid carcinomas. Despite the prominent expression of mucins and carbohydrate antigens in PTC, no significant differences were observed between PTC and follicular carcinoma thus ruling out the possibility of using the aforementioned antigens as diagnostic markers per se.

Entities:  

Year:  1999        PMID: 12114768     DOI: 10.1007/bf02739774

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  26 in total

1.  MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Authors:  I Bièche; E Ruffet; A Zweibaum; F Vildé; R Lidereau; B Franc
Journal:  Thyroid       Date:  1997-10       Impact factor: 6.568

2.  Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody.

Authors:  C A Reis; L David; P A Nielsen; H Clausen; K Mirgorodskaya; P Roepstorff; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

3.  A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.

Authors:  A Girling; J Bartkova; J Burchell; S Gendler; C Gillett; J Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

4.  Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide.

Authors:  C A Reis; T Sørensen; U Mandel; L David; E Mirgorodskaya; P Roepstorff; J Kihlberg; J E Hansen; H Clausen
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

5.  Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.

Authors:  C Hanski; K Drechsler; F G Hanisch; J Sheehan; M Manske; D Ogorek; E Klussmann; M L Hanski; M Blank; P X Xing
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

6.  Blood group antigen expression in medullary carcinoma of the thyroid. An immunohistochemical study on the occurrence of type 1 chain-derived antigens.

Authors:  M Vierbuchen; A Larena; S Schröder; F G Hanisch; M Ortmann; A Larena; G Uhlenbruck; R Fischer
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1992

7.  An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types.

Authors:  Y Yamamoto; K Izumi; H Otsuka
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

Review 8.  Structure and biology of a carcinoma-associated mucin, MUC1.

Authors:  S J Gendler; A P Spicer; E N Lalani; T Duhig; N Peat; J Burchell; L Pemberton; M Boshell; J Taylor-Papadimitriou
Journal:  Am Rev Respir Dis       Date:  1991-09

9.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

Authors:  Y Fukushi; S Hakomori; E Nudelman; N Cochran
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more
  3 in total

1.  The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression.

Authors:  Alexander Abrosimov; Vladimir Saenko; Serik Meirmanov; Masahiro Nakashima; Tatiana Rogounovitch; Olesya Shkurko; Eugeny Lushnikov; Norisato Mitsutake; Hiroyuki Namba; Shunichi Yamashita
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

Review 2.  Follicular, papillary, and "hybrid" carcinomas of the thyroid.

Authors:  Patrícia Castro; Elsa Fonseca; João Magalhães; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 3.  Amphicrine Medullary Thyroid Carcinoma - a Case-Based Review Expanding on Its MUC Expression Profile.

Authors:  Hena Khandakar; Shipra Agarwal; Mehar Chand Sharma; Devasenathipathy Kandasamy; Chandrasekhar Bal; Yashvant Rathode; Rijuta Aphale
Journal:  Endocr Pathol       Date:  2022-06-23       Impact factor: 4.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.